Copertina

Processed bulk RNA-seq data and downstream analysis scripts for iPSC-derived human liver organoids and iPS cells

Fuente: Zenodo

Salvato in:

Dettagli Bibliografici
Autore principale:	Morozumi, Ryosuke
Natura:	Recurso digital
Pubblicazione:	Zenodo 2026
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Modeling hepatic fibrosis in TP53 knockout iPSC ‐derived human liver organoids
di: Mustafa Karabicici, et al.
Pubblicazione: (2025)

Characterizing iPSC‐derived organoid models from the most prevalent retinal dystrophies
di: Arnau Navinés‐Ferrer, et al.
Pubblicazione: (2025)

Co‐Culture system for studying neuro‐inflammation pathology with iPSC derived cerebral organoid and microglia
di: Wonyoung Koh, et al.
Pubblicazione: (2025)

Aberrant neurodevelopment in human iPS cell‐derived models of Alexander disease
di: Zuzana Matusova, et al.
Pubblicazione: (2024)

The use of human iPSC‐derived alveolar organoids to explore SARS‐CoV‐2 variant infections and host responses
di: Chaitanya Gandikota, et al.
Pubblicazione: (2024)

Neuropathologic and transcriptomic analysis reveals abnormal stress response in sporadic progressive supranuclear palsy autopsy brain tissue and human iPSC‐derived midbrain organoids
di: Kristen R. Whitney, et al.
Pubblicazione: (2024)

iPSC model of human specific neuroinflammation in Alzheimer’s disease
di: Ivanna Ihnatovych, et al.
Pubblicazione: (2025)

iPSC ‐derived human cortical organoids display profound alterations of cellular homeostasis following SARS ‐ CoV ‐2 infection and Spike protein exposure
di: Gioia Cappelletti, et al.
Pubblicazione: (2025)

Sarcomeric tropomyosin expression during human iPSC differentiation into cardiomyocytes
di: Dipak K. Dube, et al.
Pubblicazione: (2024)

Alzheimer’s Disease patient stratification using iPSC‐derived hindbrain organoids as a novel pre‐clinical tool for drug testing
di: Cristina Zivko, et al.
Pubblicazione: (2024)

Toward a cure for diabetes: iPSC and ESC‐derived islet cell transplantation trials
di: Junji Fujikura, et al.
Pubblicazione: (2024)

Microglial dynamics and ferroptosis induction in human iPSC ‐derived neuron–astrocyte–microglia tri‐cultures
di: Hongmei Lisa Li, et al.
Pubblicazione: (2026)

FT538, iPSC‐derived NK cells, enhance AML cell killing when combined with chemotherapy
di: Amanda Eckstrom, et al.
Pubblicazione: (2025)

Decellularized Extracellular Matrix Produced by iPSC ‐Derived MSCs Promotes iPSC ‐ MSC Proliferation and Differentiation and Regulates Secreted Factors
di: Tao Huang, et al.
Pubblicazione: (2025)

Negatively‐correlated tRF5 expressions with mRNA and protein expressions in iPSC‐derived microglia cells in Alzheimer’s disease
di: Veena Thamilselvan, et al.
Pubblicazione: (2025)

A human iPSC‐derived neurosphere model to study functional and transcriptomic properties of microglial neuroprotection in AD
di: Stefan Wendt, et al.
Pubblicazione: (2025)

APP antisense oligonucleotides are effective in rescuing mitochondrial phenotypes in human iPSC‐derived trisomy 21 astrocytes
di: Srishruthi Thirumalai, et al.
Pubblicazione: (2025)

Human iPSC‐based models of Alzheimer’s disease
di: Yanhong Shi
Pubblicazione: (2024)

Unravelling the mechanisms of aducanumab on efficacy of Aß clearance by iPSC‐derived human microglia in 2D and 3D cell cultures
di: Ada J. Lin, et al.
Pubblicazione: (2024)

Human iPSC‐derived neuron modeling for the study of early‐onset Alzheimer’s disease
di: Phoebe Valdes, et al.
Pubblicazione: (2024)

Induction of cardiac alternans in human iPS‐derived cardiomyocytes through β‐adrenergic receptor stimulation
di: Yuto Hinata, et al.
Pubblicazione: (2024)

Engineered iPSC ‐derived natural killer cells: recent innovations in translational innate anti‐cancer immunotherapy
di: Jane Sun, et al.
Pubblicazione: (2025)

Human iPSC‐derived RPE cells implantation into minipig eye – Six weeks follow‐up study
di: Taras Ardan, et al.
Pubblicazione: (2025)

Human iPSC‐derived RPE cells implantation into minipig eye: Two weeks follow‐up study
di: Taras Ardan, et al.
Pubblicazione: (2024)

Temporal dynamics of microglial neuroprotection during chronic Aß ‐treatment in human iPSC‐derived 3D neurospheres
di: Stefan Wendt, et al.
Pubblicazione: (2024)

The isoflavone puerarin promotes generation of human iPSC‐derived pre‐oligodendrocytes and enhances endogenous remyelination in rodent models
di: Hao Xu, et al.
Pubblicazione: (2024)

Advanced modeling of Alzheimer’s disease using human iPSC‐derived microglia and neurons carrying disease‐related mutations
di: Berta Sanz Morello, et al.
Pubblicazione: (2024)

iPSC villages to understand neuroimmune changes in Alzheimer's disease
di: Martine Therrien
Pubblicazione: (2025)

Biomimetic Vascularized iPSC‐Hepatocyte Spheroids for Liver Regeneration
di: Jinglin Wang, et al.
Pubblicazione: (2024)

Injectable biodegradable microcarriers for iPSC expansion and cardiomyocyte differentiation
di: Annalisa Bettini, et al.
Pubblicazione: (2024)

Optimizing cryopreservation strategies for scalable cell therapies: A comprehensive review with insights from iPSC ‐derived therapies
di: Michael Dobruskin, et al.
Pubblicazione: (2024)

Enriching iPSC research diversity: Harnessing human biobank collections for improved ethnic representation
di: David Gurwitz, et al.
Pubblicazione: (2024)

Generation and characterization of iPSC‐derived microglia for in vitro modeling of stimuli‐specific neuroimmune responses
di: Angela K. Haskell, et al.
Pubblicazione: (2026)

Modeling iPSC-derived Endothelial Cell Transition in Tumor Angiogenesis using Petri Nets
di: Šterberová, Adéla, et al.
Pubblicazione: (2024)

Sildenafil is a candidate drug for Alzheimer’s disease: Mechanism‐of‐action observation in patient iPSC‐derived brain organoids and a 5xFAD mouse model
di: Yichen Li, et al.
Pubblicazione: (2025)

Investigation of exon skipping therapy in kidney organoids from Alport syndrome patients derived iPSCs
di: Kensuke Yabuuchi, et al.
Pubblicazione: (2024)

Early nuclear phenotypes and reactive transformation in human iPSC‐derived astrocytes from ALS patients with SOD1 mutations
di: Vincent Soubannier, et al.
Pubblicazione: (2024)

Amelioration of signaling deficits underlying metabolic shortfall in TREM2R47H human iPSC‐derived microglia
di: Foteini Vasilopoulou, et al.
Pubblicazione: (2024)

Intracellular Measurement-Informed Multiscale Modeling for Scalable iPSC Manufacturing
di: Cheng, Fuqiang, et al.
Pubblicazione: (2026)

Altered metabolic function induced by Aβ‐oligomers and PSEN1 mutations in iPSC ‐derived astrocytes
di: Richard J. Elsworthy, et al.
Pubblicazione: (2024)